Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
Trial ID or NCT#
Status
Purpose
This study will evaluate the efficacy and safety of bimatoprost SR in participants with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.
Official Title
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Eligibility Criteria
- -Diagnosis of either open-angle glaucoma or ocular hypertension in each eye and both eyes require IOP-lowering treatment.
- - Previous enrollment in another Allergan Bimatoprost SR Study. - Eye surgery (including cataract surgery) and/or any eye laser surgery within the past 6 months in the study eye - Anticipated need for laser eye surgery in either eye within the first 52 weeks of the study duration - History of glaucoma surgery
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Kristina Liu
(408) 726-5119
View on ClinicalTrials.gov